ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Status:
Completed

Trial end date:
2002-12-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the effects (good and bad) of LY231514 (ALIMTA) and Carboplatin on you and your non-small cell lung cancer.

Phase 2

Eli Lilly and Company

Carboplatin
Pemetrexed